BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tovo CV, Mattos AA, Almeida PRL. Chronic hepatitis C genotype 1 virus: Who should wait for treatment? World J Gastroenterol 2014; 20(11): 2867-2875 [PMID: 24659878 DOI: 10.3748/wjg.v20.i11.2867]
URL: https://www.wjgnet.com/1948-5182/full/v20/i11/2867.htm
Number Citing Articles
1
Anil C. Anand. Treatment of chronic hepatitis C: What is new?Apollo Medicine 2014; 11(2): 93 doi: 10.1016/j.apme.2014.05.003
2
Mary M. Ford, Ashly E. Jordan, Nirah Johnson, Eric Rude, Fabienne Laraque, Jay K. Varma, Holly Hagan. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk PopulationsJournal of Public Health Management and Practice 2018; 24(1): 41 doi: 10.1097/PHH.0000000000000519
3
Jessica L. Zuchowski, Alison B. Hamilton, Jeffrey M. Pyne, Jack A. Clark, Aanand D. Naik, Donna L. Smith, Fasiha Kanwal. Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatmentBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0356-5
4
Pia Clara Pafundi, Antonio Parrella, Domenico Iossa, Rosa Molaro, Carminia Battimelli, Erasmo Falco, Giuseppe Sodano, Riccardo Utili, Emanuele Durante-Mangoni. Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containmentJournal of Chemotherapy 2017; 29(2): 94 doi: 10.1080/1120009X.2016.1171467
5
Simona Ruta, Costin Cernescu. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypesWorld Journal of Gastroenterology 2015; 21(38): 10811-10823 doi: 10.3748/wjg.v21.i38.10811